secwatch.observer — SEC 8-K summary
======================================

Issuer:     Opus Genetics, Inc. (IRD)
CIK:        0001228627
Form:       8-K
Filed at:   2024-03-27T23:59:59+00:00
Accession:  0001140361-24-015624
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocuphire shares investor presentation; no material new details available
------------------------------------------------------------------------

- Company furnished investor presentation under Regulation FD for March 2024 meetings.
- Exhibit 99.1 content is incomplete; no specific financial or operational updates provided.
- Presentation intended for routine investor outreach; no material changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1228627/000114036124015624/0001140361-24-015624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1228627/000114036124015624/ef20025199_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-015624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer